Stay updated on Propranolol and Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Propranolol and Pembrolizumab in Melanoma Clinical Trial page
- Check4 days agoChange DetectedAdded a consolidated Locations section listing Georgia, New York, Ohio, and Pennsylvania, and removed the separate Georgia Locations, New York Locations, Ohio Locations, and Pennsylvania Locations subsections.SummaryDifference0.5%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2; no study details, navigation, or content were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedPage revision history updated from v3.2.0 to v3.3.1; no changes to trial information or study details are evident.SummaryDifference0.1%

- Check41 days agoChange DetectedThe government funding notice banner warning about potential data updates and processing delays has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check55 days agoChange DetectedThe updates seem to be minor formatting/structure changes that do not affect core study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check84 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference3%

Stay in the know with updates to Propranolol and Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.